Skip to main content

Publications

featured publications

  • Efficacy and safety of oxfendazole in adults with spp. infection in Pemba Island, Tanzania: a double-blind, phase 2a, randomised controlled trial.

    EClinicalMedicine

    Authors: Annina Schnoz, Hannah Jeanguenat, Abrahaman S Msellem, Ibrahim S Mohammed, Ramadhan S Abdalla, Salum N Seif, Amour K Amour, Mahdi J Khamis, Fabrice L Mougeni, Oleksandr Volotko, Olga Sieradzan, Karen Dequatre Cheeseman, George M Nyangweso, Thaddaeus W Egondi, Fabiana Barreira, Marc P Hübner, Sonja Zehetmayer, Said M Ali, Jennifer Keiser

  • Long-term outcomes of the PAUL Glaucoma Implant Versus Ahmed Glaucoma Valve.

    The British journal of ophthalmology

    Authors: Constance Liegl, Lara Buhl, Benjamin Aretz, Siegfried Priglinger, Frank G Holz, Raffael Liegl, Marc Mackert, Karl Mercieca

  • Endothelial p16 expression identifies a subgroup of clear cell renal cell carcinoma with favorable prognosis.

    BMC cancer

    Authors: Michael Stoffel, Katharina Baschun, Melina Kehl, Jörg Ellinger, Niklas Klümper, Sebastian Kadzik, Franziska I Winterhagen, Manuel Ritter, Michael Hölzel, Glen Kristiansen, Marieta I Toma

  • Effect of aging on neutrophil function in humans.

    Cellular immunology

    Authors: Joelle Noriko Galang, Nicholas A Sumpter, Titus Schlüter, Nils Asmann, Laura Merlo Pich, Andrei Sarlea, Frank van de Veerdonk, Athanasios Ziogas, Mihai G Netea

  • Longitudinal analysis of structural biomarkers for disease progression in intermediate age-related macular degeneration: a MACUSTAR study report.

    Ophthalmology. Retina

    Authors: Lukas Goerdt, Danielle Bessaheken, Jan H Terheyden, Sarah Thiele, Vanessa Basten, Charlotte Behning, Ulrich Luhmann, Sergio Leal, Klaus-Peter Moll, Nadia Zakaria, Matthias Schmid, Robert P Finger, Frank G Holz, Steffen Schmitz-Valckenberg, Marlene Saßmannshausen

  • NanoBRET Target Engagement Enables Validation of p53 Y220C Ligands in a Cellular Context.

    Journal of medicinal chemistry

    Authors: Dominika Ewa Pieńkowska, Xijun Zhu, Nathanael S Gray, Radosław P Nowak

  • Firstline treatment with ruxolitinib versus best available therapy in patients with polycythemia vera: results from the randomized RuxoBEAT trial.

    Blood cancer journal

    Authors: Steffen Koschmieder, Susanne Isfort, Lino L Teichmann, Philippe Schafhausen, Florian H Heidel, Carl Crodel, Andreas Hochhaus, Martin Griesshammer, Katja Sockel, Philipp J Jost, Denise Walther, Konstanze Döhner, Joachim R Göthert, Markus Radsak, Marinela Augustin, Heiko Becker, Aristoteles Giagounidis, Markus Schaich, Martine Klausmann, Nikolas von Bubnoff, Frank Stegelmann, Maike Kortmann, Michelle Zentis, Julia Frank, Anna Hagemeier, Martin Hellmich, Tim H Brümmendorf

  • EudraScore: Modification of the Vigi4Eudra-score for the Assessment of the Completeness of Adverse Drug Reaction Reports in EudraVigilance.

    Drug safety

    Authors: Diana Dubrall, Patrick Christ, Dennis Lex, Robert Hoffmann, Thomas Grüger, Matthias Schmid, Bernhardt Sachs

  • G-quadruplex structures affect the immune response to bacterial infection in mouse macrophages.

    Nature communications

    Authors: Philipp Schult, Melanie Kastl, Jennifer Szlapa, Konstantinos Symeonidis, Salie Maasewerd, Bernardo Franklin, Alea Radcke, Stefan A Juranek, Zeinab Abdullah, Katrin Paeschke

  • Correction: Aflibercept 8 mg in neovascular age-related macular degeneration and diabetic macular oedema: Translating clinical trials into clinical practice.

    Eye (London, England)

    Authors: Sobha Sivaprasad, Michael W Stewart, Charles C Wykoff, David Eichenbaum, Jean-Francois Korobelnik, Paolo Lanzetta, Varun Chaudhary, Chui Ming Gemmy Cheung, Richard Gale, Marion R Munk, Taiji Sakamoto, Andreas Stahl, Javier Zarranz-Ventura, Tien Yin Wong, Frank G Holz, Anat Loewenstein